Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
130M
Number of holders
208
Total 13F shares, excl. options
73.2M
Shares change
-5.08M
Total reported value, excl. options
$923M
Value change
-$107M
Put/Call ratio
0
Number of buys
125
Number of sells
-75
Price
$12.61

Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q4 2018

229 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q4 2018.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73.2M shares of 130M outstanding shares and own 56.47% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (5.89M shares), BlackRock Inc. (5.52M shares), Vanguard Group Inc (4.09M shares), BROWN ADVISORY INC (2.44M shares), EAGLE ASSET MANAGEMENT INC (2.27M shares), ELEMENT CAPITAL MANAGEMENT LLC (2.24M shares), First Light Asset Management, LLC (2.21M shares), CARILLON TOWER ADVISERS, INC. (2M shares), EMERALD ADVISERS, LLC (1.91M shares), and EMERALD MUTUAL FUND ADVISERS TRUST (1.83M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.